LMN-201 for Prevention of C. Difficile Infection Recurrence
Condition: Clostridioides Difficile Infection Interventions: Drug: LMN-201; Drug: Placebo Sponsor: Lumen Bioscience, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Clostridium Difficile | Research